carvacrol has been researched along with Demyelinating Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, YL; Huh, Y; Jung, J; Kim, M; Kim, N; Kim, YH; Park, C; Yang, H | 1 |
1 other study(ies) available for carvacrol and Demyelinating Diseases
| Article | Year |
|---|---|
Carvacrol effectively protects demyelination by suppressing transient receptor potential melastatin 7 (TRPM7) in Schwann cells.
Topics: Cells, Cultured; Cymenes; Demyelinating Diseases; Humans; Neurodegenerative Diseases; Origanum; Phytotherapy; Protein Serine-Threonine Kinases; Schwann Cells; Sciatic Nerve; TRPM Cation Channels; Up-Regulation | 2020 |